Synthesis and structure–activity relationship of new analogues of antistasin
✍ Scribed by Dr Dantcho L. Danalev; Lyubomir T. Vezenkov; Boryana Grigorova
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 129 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1075-2617
- DOI
- 10.1002/psc.464
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Intensive investigation connected with the development of new anticoagulant agents for the treatment of cardiovascular diseases was carried out. Direct and specific inhibition of thrombin and Factor Xa–like serine proteases in the coagulation cascade has been the focus of many efforts to design novel anticoagulants over the past decade. This work reports the synthesis and biological activity of new anticoagulant peptide analogues of natural isoforms 2 and 3 of antistasin. In addition they include different tripeptide sequences in their molecules, which are highly active inhibitors of different serine proteases such as plasmin, trypsin, thrombin and Factor Xa. Copyright © 2003 European Peptide Society and John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
AbstractÐOpioid binding anities were assessed for a series of cyclazocine analogues where the prototypic 8-OH substituent of cyclazocine was replaced by amino and substituted-amino groups. For m and k opioid receptors, secondary amine derivatives having the (2R,6R,11R)-con®guration had the highest a
## Abstract Several recently discovered marine products have remarkable in vitro and in vivo anticancer profiles against a wide range of tumor cell lines. Some of these compounds are currently in clinical trials. These compounds show complex structures and mechanisms of action of interest. Herein,
Four novel ustiloxin D analogues were synthesized focusing on the size of the macrocyclic core, the stereochemistry at the bridgehead ether, and the enantiomer of ustiloxin D. All four were subjected to biological evaluation testing the inhibition of tubulin polymerization. Only 2,2-dimethyl-ustilox